Real change begins
with clarity
Backed by medical evidence, MORROW Insights
bring clarity and direction.
Backed by medical evidence, MORROW Insights bring clarity and direction.
Precision screening to measure what matters.
This is where longevity medicine finally becomes accessible to more people, helping democratise proactive, preventive care. By uniting screening with behavioural insight, we move you from screening to meaningful, sustained change.
STEP 1: TESTS
One clear starting point.
Your journey begins with an essential biomarker panel that offers insight into inflammation, metabolic health, nutrient status, body composition and overall physiological resilience.
Grounded in lifestyle medicine, we help you connect the dots between your data, daily habits, and long-term health. Complex information becomes clear, practical, and actionable—giving you a roadmap that supports prevention, performance, and sustained well-being.
STEP 2: UNDERSTAND YOUR RESULTS
Change grows in community.
MORROW’s group discussion is a 90-min doctor-led group session among 6-10 people, explaining key outputs, common patterns, and how to interpret the screening results.
Explore how lifestyle factors influence long-term health. The benefits include:
Better understanding through shared learning: Learn from answers you didn’t know you were looking for
More time allocated for education and explanation
Engaging and dynamic discussions make the session interactive and memorable
Evidence-based approach for behaviour change: Supports commitment to health recommendations
Note: Group discussions do not replace the 1:1 consultation. Patients who attend it are expected to follow up with a 1:1 consultation for a personalised management plan. For individuals with more complex conditions, a 1:1 consultation may be recommended. Alternatively, patients may choose to consult their preferred general practitioner.
STEP 3: PERSONALISE YOUR PATH
Clarity, when it matters most.
For individuals who want a deeper, more personalised understanding of their health, a 45-minute 1:1 consultation with a MORROW doctor offers dedicated time to interpret results in context and plan next steps.
This consultation is suitable for anyone seeking greater clarity—and is especially helpful when results raise questions, reveal abnormalities, or warrant more detailed discussion and guidance.
This personalised consultation allows more time to review your results in context, align them with your goals, and build a prioritised action plan.
Backed by our wider network of allied health experts, recommendations are designed with downstream support in mind—so next steps across lifestyle medicine remain integrated, realistic, and sustainable. While these specialists are not present during the consultation, their expertise informs the pathways we guide you toward.
For those who want to go even further, targeted add-ons tests are available to explore specific areas in your health.
What’s inside your insights
What we test
Biomarkers covering metabolism, inflammation, organ function, nutrition and physical performance.
What it indicates
These markers reveal how your body is working today — highlighting strengths, early shifts, and areas that may need attention.
What you can do about it
Your results are translated into clear, practical steps through a guided discussion, helping you take informed actions that fits your daily life. For additional support, a health coach may be recommended.
Here’s how we use your test results to support clarity and action:
Cardiorespiratory health
A combined view of cardiovascular health and cardiorespiratory fitness, showing both disease risk and functional capacity that influence long-term healthspan.
Metabolic health
How well your body manages energy today to protect your health over the long term.
Musculoskeletal health
Strength and bone health that preserve mobility, independence and quality of life as you age.
Psychological well-being
Insights into mental and emotional health that influence daily functioning, resilience and long-term healthspan.
Haematology
FBC
Full blood count checks if your blood cells are healthy, helping identify signs of infection, inflammation or other blood-related changes.
Blood film
Looks closely at the shape and appearance of blood cells to spot abnormalities not visible in standard counts.
Disclaimer
Haematology
FBC
Full blood count checks if your blood cells are healthy, helping identify signs of infection, inflammation or other blood-related changes.
Blood film
Looks closely at the shape and appearance of blood cells to spot abnormalities not visible in standard counts.
Disclaimer
Glucose
HbA1c
Hemoglobin A1c shows your average blood sugar levels over the past 3 months.
Fasting glucose and insulin
Assess how your body regulates blood sugar and can highlight early changes in insulin sensitivity.
Disclaimer
Glucose
HbA1c
Hemoglobin A1c shows your average blood sugar levels over the past 3 months.
Fasting glucose and insulin
Assess how your body regulates blood sugar and can highlight early changes in insulin sensitivity.
Disclaimer
Kidney function
Sodium/potassium/chloride
Assesses fluid and electrolyte balance, which the kidneys help regulate.
Urea
Provides context on waste product handling, interpreted alongside hydration, diet and kidney function.
Disclaimer
Creatinine
Measures kidney filtering efficiency.
Disclaimer
eGFR
Estimated glomerular filtration rate gives an overall estimate of kidney function.
Disclaimer
Bicarbonate
Shows how well your body maintains healthy acid–base balance.
Disclaimer
Calcium
Assesses total and corrected calcium balance, interpreted alongside kidney function and other markers.
Disclaimer
Phosphate
Assesses phosphate balance, interpreted in the context of overall metabolic and kidney health.
Disclaimer
Urinalysis
Screens for early signs of kidney issues, infection, or metabolic problems.
Disclaimer
UACR
Urine albumin–creatatinine ratio is a simple urine test that detects early kidney damage by measuring protein leakage—often before symptoms appear. Elevated levels also signal increased cardiovascular risk, enabling early, preventive action.
Disclaimer
Kidney function
Sodium/potassium/chloride
Assesses fluid and electrolyte balance, which the kidneys help regulate.
Urea
Provides context on waste product handling, interpreted alongside hydration, diet and kidney function.
Disclaimer
Creatinine
Measures kidney filtering efficiency.
Disclaimer
eGFR
Estimated glomerular filtration rate gives an overall estimate of kidney function.
Disclaimer
Bicarbonate
Shows how well your body maintains healthy acid–base balance.
Disclaimer
Calcium
Assesses total and corrected calcium balance, interpreted alongside kidney function and other markers.
Disclaimer
Phosphate
Assesses phosphate balance, interpreted in the context of overall metabolic and kidney health.
Disclaimer
Urinalysis
Screens for early signs of kidney issues, infection, or metabolic problems.
Disclaimer
UACR
Urine albumin–creatatinine ratio is a simple urine test that detects early kidney damage by measuring protein leakage—often before symptoms appear. Elevated levels also signal increased cardiovascular risk, enabling early, preventive action.
Disclaimer
Liver function
Total Protein
Provides an overview of protein balance in the blood, influenced by liver synthesis, nutrition and immune activity.
Albumin
Reflects longer-term protein production, interpreted in the context of inflammation, nutritional status, liver function, and overall health.
Disclaimer
Globulin
Represents immune-related proteins and provides context on immune activity.
Disclaimer
A/G ratio
Shows the balance between albumin and globulin.
Disclaimer
ALP
Alkaline phosphatase test helps assess bile flow or bone-related activity, interpreted alongside other markers.
Disclaimer
Total bilirubin
Provides insight into how bilirubin is processed and cleared.
Disclaimer
Indirect bilirubin
Helps clarify the cause of raised bilirubin levels.
Disclaimer
GGT
Gamma-glutamyl transferase is a sensitive marker of liver or bile duct stress, influenced by alcohol, medications and metabolic factors.
Disclaimer
AST
Aspartate transaminase is an enzyme that rises with liver or muscle stress.
Disclaimer
ALT
Alanine transaminase is an enzyme more specific to liver cell stress.
Disclaimer
Liver function
Total Protein
Provides an overview of protein balance in the blood, influenced by liver synthesis, nutrition and immune activity.
Albumin
Reflects longer-term protein production, interpreted in the context of inflammation, nutritional status, liver function, and overall health.
Disclaimer
Globulin
Represents immune-related proteins and provides context on immune activity.
Disclaimer
A/G ratio
Shows the balance between albumin and globulin.
Disclaimer
ALP
Alkaline phosphatase test helps assess bile flow or bone-related activity, interpreted alongside other markers.
Disclaimer
Total bilirubin
Provides insight into how bilirubin is processed and cleared.
Disclaimer
Indirect bilirubin
Helps clarify the cause of raised bilirubin levels.
Disclaimer
GGT
Gamma-glutamyl transferase is a sensitive marker of liver or bile duct stress, influenced by alcohol, medications and metabolic factors.
Disclaimer
AST
Aspartate transaminase is an enzyme that rises with liver or muscle stress.
Disclaimer
ALT
Alanine transaminase is an enzyme more specific to liver cell stress.
Disclaimer
Lipid panel
Total cholesterol
Measures overall cholesterol levels.
HDL
High-density lipoprotein is “good” cholesterol that supports heart health.
Disclaimer
LDL
Low-density lipoprotein is “bad” cholesterol that can build up in arteries.
Disclaimer
Triglycerides
Blood fats linked to metabolic and heart disease risk.
Disclaimer
Cholesterol/HDL ratio
Combined measure used to estimate heart-related risk.
Disclaimer
Lipid panel
Total cholesterol
Measures overall cholesterol levels.
HDL
High-density lipoprotein is “good” cholesterol that supports heart health.
Disclaimer
LDL
Low-density lipoprotein is “bad” cholesterol that can build up in arteries.
Disclaimer
Triglycerides
Blood fats linked to metabolic and heart disease risk.
Disclaimer
Cholesterol/HDL ratio
Combined measure used to estimate heart-related risk.
Disclaimer
Inflammation
Hs-CRP
High-sensitivity C-reactive protein is a marker of low-grade inflammation in the body, linked to cardiovascular risk.
Ferritin
Reflects iron storage levels and can be influenced by both iron status and inflammation.
Disclaimer
Inflammation
Hs-CRP
High-sensitivity C-reactive protein is a marker of low-grade inflammation in the body, linked to cardiovascular risk.
Ferritin
Reflects iron storage levels and can be influenced by both iron status and inflammation.
Disclaimer
Nutritional markers
Iron
Provides information about circulating iron levels.
Transferrin
Reflects the body’s iron transport capacity, supporting interpretation of iron availability.
Disclaimer
TIBC
Measures the blood’s capacity to carry iron.
Disclaimer
Saturation
Shows how much transferrin is filled with iron, clarifying whether iron is relatively low or adequate.
Disclaimer
Vitamin B12 and folate
Key nutrients involved in red blood cell production and nervous system function.
Disclaimer
Vitamin D
Key nutrient for bones and immune health.
Disclaimer
Nutritional markers
Iron
Provides information about circulating iron levels.
Transferrin
Reflects the body’s iron transport capacity, supporting interpretation of iron availability.
Disclaimer
TIBC
Measures the blood’s capacity to carry iron.
Disclaimer
Saturation
Shows how much transferrin is filled with iron, clarifying whether iron is relatively low or adequate.
Disclaimer
Vitamin B12 and folate
Key nutrients involved in red blood cell production and nervous system function.
Disclaimer
Vitamin D
Key nutrient for bones and immune health.
Disclaimer
DEXA
Body fat %
Shows overall body fat levels, helping guide metabolic and lifestyle strategies beyond weight alone.
Visceral fat
Assesses fat around organs, which carries higher metabolic risk.
Disclaimer
Lean mass
Reflects muscle quantity, supporting strength and healthy ageing strategies.
Disclaimer
Bone mineral density
Provides information on bone strength.
Disclaimer
Android/gynoid fat ratio
Shows if fat is carried more around the belly or hips, offering additional insight into metabolic patterns.
Disclaimer
Left-to-right muscle balance
Highlights muscle imbalance between the right and left side, guiding movement or strength planning.
Disclaimer
DEXA
Body fat %
Shows overall body fat levels, helping guide metabolic and lifestyle strategies beyond weight alone.
Visceral fat
Assesses fat around organs, which carries higher metabolic risk.
Disclaimer
Lean mass
Reflects muscle quantity, supporting strength and healthy ageing strategies.
Disclaimer
Bone mineral density
Provides information on bone strength.
Disclaimer
Android/gynoid fat ratio
Shows if fat is carried more around the belly or hips, offering additional insight into metabolic patterns.
Disclaimer
Left-to-right muscle balance
Highlights muscle imbalance between the right and left side, guiding movement or strength planning.
Disclaimer
Disclaimer: DEXA scanning involves exposure to low-dose ionising radiation.
This test is not recommended if you are pregnant, may be pregnant, or are breastfeeding. Please inform our staff if any of these apply to you.
Disclaimer: DEXA scanning involves exposure to low-dose ionising radiation. This test is not recommended if you are pregnant, may be pregnant, or are breastfeeding. Please inform our staff if any of these apply to you.
VO₂ max
VO₂ max
Measures how efficiently your body delivers and uses oxygen during exercise. It is a gold-standard marker of cardiovascular fitness and one of the strongest predictors of long-term health and longevity. This 8–12 minute progressive exercise test provides a clear snapshot of your cardiorespiratory fitness. It evaluates how effectively the heart, lungs, and muscles work together, with results benchmarked against age- and sex-matched norms to identify potential fitness limitations. The test is time-efficient and closely monitored, following a full ramp protocol that progresses to maximal effort, ensuring robust, accurate, and meaningful results.
VO₂ max
VO₂ max
Measures how efficiently your body delivers and uses oxygen during exercise. It is a gold-standard marker of cardiovascular fitness and one of the strongest predictors of long-term health and longevity. This 8–12 minute progressive exercise test provides a clear snapshot of your cardiorespiratory fitness. It evaluates how effectively the heart, lungs, and muscles work together, with results benchmarked against age- and sex-matched norms to identify potential fitness limitations. The test is time-efficient and closely monitored, following a full ramp protocol that progresses to maximal effort, ensuring robust, accurate, and meaningful results.
Strength and power
Countermovement jump
A force plate assessment of lower body neuromuscular power, reflecting the ability to rapidly produce force and absorb load, which are qualities that are closely linked to athletic performance, functional movement and fall risk across the life span.
Isometric mid-thigh pull
Measures overall strength and force production. Assesses full body maximal strength by measuring peak force production in isometric conditions, a key determinant of musculoskeletal health, physical robustness, and long term functional independence.
Disclaimer
Grip strength
Grip strength reliably measures upper body strength and neuromuscular function, and serves as a valid indicator for age-related health risks, mortality, and physical frailty.
Disclaimer
Strength and power
Countermovement jump
A force plate assessment of lower body neuromuscular power, reflecting the ability to rapidly produce force and absorb load, which are qualities that are closely linked to athletic performance, functional movement and fall risk across the life span.
Isometric mid-thigh pull
Measures overall strength and force production. Assesses full body maximal strength by measuring peak force production in isometric conditions, a key determinant of musculoskeletal health, physical robustness, and long term functional independence.
Disclaimer
Grip strength
Grip strength reliably measures upper body strength and neuromuscular function, and serves as a valid indicator for age-related health risks, mortality, and physical frailty.
Disclaimer
ECG
ECG
Electrocardiogram Records your heart’s electrical signals to assess rhythm and activity.
ECG
ECG
Electrocardiogram Records your heart’s electrical signals to assess rhythm and activity.
Spirometry
Spirometry test
Checks lung capacity and airflow to assess respiratory function.
Spirometry
Spirometry test
Checks lung capacity and airflow to assess respiratory function.
Vitals
Blood pressure
Measures pressure in your arteries, an important heart-health indicator.
SpO₂
Peripheral oxygen saturation measures oxygen levels in your blood.
Disclaimer
Height
Basic measurement for body profiling and BMI calculation.
Disclaimer
Weight
Measures body mass.
Disclaimer
BMI
Body mass index is weight-for-height ratio used to classify body size.
Disclaimer
Waist circumference
Indicates abdominal fat, linked to metabolic risk.
Disclaimer
Vitals
Blood pressure
Measures pressure in your arteries, an important heart-health indicator.
SpO₂
Peripheral oxygen saturation measures oxygen levels in your blood.
Disclaimer
Height
Basic measurement for body profiling and BMI calculation.
Disclaimer
Weight
Measures body mass.
Disclaimer
BMI
Body mass index is weight-for-height ratio used to classify body size.
Disclaimer
Waist circumference
Indicates abdominal fat, linked to metabolic risk.
Disclaimer
Haematology
FBC
Full blood count checks if your blood cells are healthy, helping identify signs of infection, inflammation or other blood-related changes.
Blood film
Looks closely at the shape and appearance of blood cells to spot abnormalities not visible in standard counts.
Disclaimer
Haematology
FBC
Full blood count checks if your blood cells are healthy, helping identify signs of infection, inflammation or other blood-related changes.
Blood film
Looks closely at the shape and appearance of blood cells to spot abnormalities not visible in standard counts.
Disclaimer
MORROW Insights
Change begins with clarity
Your personalised lifestyle medicine roadmap, made accessible—offering clarity, insight, and the information on your current health to make meaningful, self-directed choices.
Includes a health screening and a doctor-led group discussion to understand your results
$599
$599
Screening will take 2.5 hours
1:1 consultation can be purchased online or in-person after your group discussion.
Only Singapore residents may sign up for MORROW Insights.
Patients under the age of 21 will require parent or guardian consent.
Terms and conditions apply
Prices exclude GST
We may recommend a personal consultation if your health requires dedicated time after assessment
Add-ons
Take the next step deeper into your health, with targeted areas of focus.
Preventive panel bundle
Preventive Tier 1
bundle
$1299
(Includes 1:1 doctor consultation)
A comprehensive screening panel for health-conscious individuals who want to identify hidden cardiovascular, metabolic, and cancer risks before symptoms appear. This bundle combines advanced lipid analysis, multi-cancer early detection, and foundational metabolic screening to reveal risks that standard panels miss.
Who this panel is for
For individuals who want real clarity on cardiovascular risk—especially if you have a family history, are a high performer, or want deeper clarity beyond basic cholesterol testing.
What this panel helps you understand
Whether your risk is truly low or simply “normal” on standard tests
If plaque formation or vascular stress is developing quietly
Whether your lipid profile is protective or harmful over the long-term
What it looks at
A deeper view of heart health, including:
Cholesterol particle quality, not just total cholesterol numbers
Inflammatory signals affecting blood vessels
Early markers of cardiovascular strain before symptoms appear
Why this matters
Heart disease is often silent until late stages
Standard tests can miss risk in fit, lean, or active individuals
Earlier insight creates more room for prevention and course correction
How this supports better decisions
Enables more personalised nutrition beyond generic “heart-healthy” advice
Guides the right type and intensity of exercise
Clarifies when lifestyle optimisation is enough and when closer monitoring is needed
Panel includes:
NT-proBNP
N-terminal pro-B-type natriuretic peptide is a hormone released when the heart muscle is under strain. Elevated levels signal early cardiac stress from conditions such as high blood pressure, valve disease, or developing heart failure—often long before symptoms like breathlessness or fatigue appear. NT-proBNP offers early clarity on how the heart is responding to strain, helping guide timely lifestyle or care adjustments and track changes over time.
Disclaimer
Homocysteine
Homocysteine is an amino acid produced during protein metabolism that can damage blood vessel walls when elevated. High levels are independently linked to heart attack, stroke, peripheral artery disease, and dementia, driven by vascular inflammation and plaque formation. Homocysteine also reflects functional status of key B vitamins—B12, folate, and B6—and is highly actionable, as levels often improve with targeted nutritional intervention, making it valuable for cardiovascular and brain risk optimisation.
Disclaimer
ApoA1
Apolipoprotein A1 is the main structural protein of HDL particles responsible for removing cholesterol from artery walls and transporting it back to the liver. Measuring ApoA1 reflects the number and effectiveness of protective HDL particles rather than cholesterol content alone, which can be misleading. Higher levels are associated with stronger cardiovascular protection, while lower levels indicate impaired cholesterol clearance even when HDL cholesterol appears normal.
Disclaimer
ApoB/ApoA1 ratio
Apolipoprotein B/Apolipoprotein A1 ratio represents the balance between atherogenic particles and protective HDL particles in a single, powerful metric. It captures net cardiovascular risk more accurately than traditional cholesterol ratios, showing whether harmful particles outweigh the body's ability to clear them. Lower ratios indicate favourable lipid balance and reduced cardiovascular risk, while higher ratios signal the need for intervention.
Disclaimer
Lp(a)
Lipoprotein(a), or lipoprotein little a, is a genetically determined LDL-like particle with an added protein that promotes inflammation and clot formation. Levels are largely fixed for life and minimally influenced by lifestyle, yet significantly increase risk of heart attack, stroke, and aortic valve disease. Testing Lp(a) enables lifetime risk stratification and identifies individuals who benefit from more aggressive management of all modifiable cardiovascular risk factors. Elevated levels warrant enhanced prevention efforts.
Disclaimer
Who this panel is for
For individuals who want real clarity on cardiovascular risk—especially if you have a family history, are a high performer, or want deeper clarity beyond basic cholesterol testing.
What this panel helps you understand
Whether your risk is truly low or simply “normal” on standard tests
If plaque formation or vascular stress is developing quietly
Whether your lipid profile is protective or harmful over the long-term
What it looks at
A deeper view of heart health, including:
Cholesterol particle quality, not just total cholesterol numbers
Inflammatory signals affecting blood vessels
Early markers of cardiovascular strain before symptoms appear
Why this matters
Heart disease is often silent until late stages
Standard tests can miss risk in fit, lean, or active individuals
Earlier insight creates more room for prevention and course correction
How this supports better decisions
Enables more personalised nutrition beyond generic “heart-healthy” advice
Guides the right type and intensity of exercise
Clarifies when lifestyle optimisation is enough and when closer monitoring is needed
Panel includes:
NT-proBNP
N-terminal pro-B-type natriuretic peptide is a hormone released when the heart muscle is under strain. Elevated levels signal early cardiac stress from conditions such as high blood pressure, valve disease, or developing heart failure—often long before symptoms like breathlessness or fatigue appear. NT-proBNP offers early clarity on how the heart is responding to strain, helping guide timely lifestyle or care adjustments and track changes over time.
Disclaimer
Homocysteine
Homocysteine is an amino acid produced during protein metabolism that can damage blood vessel walls when elevated. High levels are independently linked to heart attack, stroke, peripheral artery disease, and dementia, driven by vascular inflammation and plaque formation. Homocysteine also reflects functional status of key B vitamins—B12, folate, and B6—and is highly actionable, as levels often improve with targeted nutritional intervention, making it valuable for cardiovascular and brain risk optimisation.
Disclaimer
ApoA1
Apolipoprotein A1 is the main structural protein of HDL particles responsible for removing cholesterol from artery walls and transporting it back to the liver. Measuring ApoA1 reflects the number and effectiveness of protective HDL particles rather than cholesterol content alone, which can be misleading. Higher levels are associated with stronger cardiovascular protection, while lower levels indicate impaired cholesterol clearance even when HDL cholesterol appears normal.
Disclaimer
ApoB/ApoA1 ratio
Apolipoprotein B/Apolipoprotein A1 ratio represents the balance between atherogenic particles and protective HDL particles in a single, powerful metric. It captures net cardiovascular risk more accurately than traditional cholesterol ratios, showing whether harmful particles outweigh the body's ability to clear them. Lower ratios indicate favourable lipid balance and reduced cardiovascular risk, while higher ratios signal the need for intervention.
Disclaimer
Lp(a)
Lipoprotein(a), or lipoprotein little a, is a genetically determined LDL-like particle with an added protein that promotes inflammation and clot formation. Levels are largely fixed for life and minimally influenced by lifestyle, yet significantly increase risk of heart attack, stroke, and aortic valve disease. Testing Lp(a) enables lifetime risk stratification and identifies individuals who benefit from more aggressive management of all modifiable cardiovascular risk factors. Elevated levels warrant enhanced prevention efforts.
Disclaimer
Who this panel is for
For individuals thinking long-term about memory, focus, and cognitive resilience—especially those with a family history of dementia, demanding mental workloads, or concerns about future brain health.
What this panel helps you understand
Whether you may be at higher risk of cognitive decline later in life
If inflammation or metabolic stress is affecting brain health today
Whether your lifestyle is supporting long-term mental sharpness
What it looks at
A foundational neuro-metabolic screening that evaluates thyroid function, omega-3 status, vascular integrity (homocysteine), and includes cognitive assessment testing to establish your baseline cognitive performance. When combined with the comprehensive metabolic and inflammatory markers in your core screening—and ideally paired with the Preventive Heart Package for complete vascular assessment—these tests provide a more complete picture of the modifiable factors influencing brain health.
Why this matters
Cognitive decline often begins years—sometimes decades—before symptoms appear
Early insight creates more opportunity for prevention
Lifestyle changes can meaningfully influence long-term brain outcomes
How this supports better decisions
Guides targeted changes to diet, sleep, and exercise for brain health
Helps prioritise stress management and recovery
Enables trend monitoring over time rather than waiting for symptoms
Panel includes:
Omega-3 index (neurological focus)
The Omega-3 Index measures the proportion of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in red blood cell membranes, reflecting long-term omega-3 status. DHA is a key structural fat in the brain, supporting neuronal integrity, neurotransmission, mood regulation, and neuroprotection. Higher levels are linked to better cognition, emotional resilience, and lower risk of cognitive decline, while low levels are associated with depression and accelerated brain ageing. This test guides targeted omega-3 supplementation to support optimal brain health.
Disclaimer
TSH
Thyroid stimulating hormone regulates thyroid hormone production and is the primary marker of thyroid function. Thyroid hormones are critical for brain metabolism, neurotransmitter balance, and cognitive speed, making subtle dysfunction clinically meaningful. Elevated TSH suggests underactive thyroid activity linked to brain fog and low mood, while low TSH reflects overactivity associated with anxiety and impaired focus. For cognitive optimisation, TSH is best maintained within a tighter range than standard reference values, which your physician will determine based on your symptoms and overall thyroid profile.
Disclaimer
FT4
Free thyroxine represents the circulating reserve of thyroid hormone produced by the thyroid gland. Adequate FT4 is necessary to supply sufficient substrate for conversion into active T3, supporting brain energy and mental clarity. Low or low-normal FT4 can contribute to cognitive symptoms even when TSH appears normal. FT4 helps assess thyroid production capacity, with optimal cognitive support typically seen in the mid-to-upper reference range.
Disclaimer
FT3
Free triiodothyronine is the active thyroid hormone that directly drives brain and cellular metabolism. Impaired conversion from T4 to T3—often due to stress, inflammation, or nutrient deficiencies—can result in brain fog and mental fatigue despite normal TSH and FT4. Measuring FT3 identifies activation issues missed by standard screening and is key for cognitive optimisation, with best function generally in the mid-to-upper reference range.
Disclaimer
Homocysteine
Homocysteine is an amino acid that when elevated can damage blood vessel walls and is independently linked to cognitive decline, dementia risk, and vascular damage to the brain. High levels reflect impaired B-vitamin metabolism (B12, folate, B6) and contribute to vascular inflammation affecting brain health. Homocysteine is highly actionable—levels often improve with targeted nutritional intervention. For brain health optimisation, lower levels support better vascular integrity and reduced dementia risk.
Disclaimer
Cognitive assessment
A standardised cognitive assessment establishes your baseline cognitive performance across key domains including memory, attention, processing speed, and executive function. This baseline enables meaningful tracking over time, helping distinguish normal age-related changes from early cognitive decline. Regular assessment allows for earlier intervention if changes are detected, and provides objective data to guide lifestyle modifications aimed at maintaining cognitive health.
Disclaimer
Who this panel is for
For individuals thinking long-term about memory, focus, and cognitive resilience—especially those with a family history of dementia, demanding mental workloads, or concerns about future brain health.
What this panel helps you understand
Whether you may be at higher risk of cognitive decline later in life
If inflammation or metabolic stress is affecting brain health today
Whether your lifestyle is supporting long-term mental sharpness
What it looks at
A foundational neuro-metabolic screening that evaluates thyroid function, omega-3 status, vascular integrity (homocysteine), and includes cognitive assessment testing to establish your baseline cognitive performance. When combined with the comprehensive metabolic and inflammatory markers in your core screening—and ideally paired with the Preventive Heart Package for complete vascular assessment—these tests provide a more complete picture of the modifiable factors influencing brain health.
Why this matters
Cognitive decline often begins years—sometimes decades—before symptoms appear
Early insight creates more opportunity for prevention
Lifestyle changes can meaningfully influence long-term brain outcomes
How this supports better decisions
Guides targeted changes to diet, sleep, and exercise for brain health
Helps prioritise stress management and recovery
Enables trend monitoring over time rather than waiting for symptoms
Panel includes:
Omega-3 index (neurological focus)
The Omega-3 Index measures the proportion of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in red blood cell membranes, reflecting long-term omega-3 status. DHA is a key structural fat in the brain, supporting neuronal integrity, neurotransmission, mood regulation, and neuroprotection. Higher levels are linked to better cognition, emotional resilience, and lower risk of cognitive decline, while low levels are associated with depression and accelerated brain ageing. This test guides targeted omega-3 supplementation to support optimal brain health.
Disclaimer
TSH
Thyroid stimulating hormone regulates thyroid hormone production and is the primary marker of thyroid function. Thyroid hormones are critical for brain metabolism, neurotransmitter balance, and cognitive speed, making subtle dysfunction clinically meaningful. Elevated TSH suggests underactive thyroid activity linked to brain fog and low mood, while low TSH reflects overactivity associated with anxiety and impaired focus. For cognitive optimisation, TSH is best maintained within a tighter range than standard reference values, which your physician will determine based on your symptoms and overall thyroid profile.
Disclaimer
FT4
Free thyroxine represents the circulating reserve of thyroid hormone produced by the thyroid gland. Adequate FT4 is necessary to supply sufficient substrate for conversion into active T3, supporting brain energy and mental clarity. Low or low-normal FT4 can contribute to cognitive symptoms even when TSH appears normal. FT4 helps assess thyroid production capacity, with optimal cognitive support typically seen in the mid-to-upper reference range.
Disclaimer
FT3
Free triiodothyronine is the active thyroid hormone that directly drives brain and cellular metabolism. Impaired conversion from T4 to T3—often due to stress, inflammation, or nutrient deficiencies—can result in brain fog and mental fatigue despite normal TSH and FT4. Measuring FT3 identifies activation issues missed by standard screening and is key for cognitive optimisation, with best function generally in the mid-to-upper reference range.
Disclaimer
Homocysteine
Homocysteine is an amino acid that when elevated can damage blood vessel walls and is independently linked to cognitive decline, dementia risk, and vascular damage to the brain. High levels reflect impaired B-vitamin metabolism (B12, folate, B6) and contribute to vascular inflammation affecting brain health. Homocysteine is highly actionable—levels often improve with targeted nutritional intervention. For brain health optimisation, lower levels support better vascular integrity and reduced dementia risk.
Disclaimer
Cognitive assessment
A standardised cognitive assessment establishes your baseline cognitive performance across key domains including memory, attention, processing speed, and executive function. This baseline enables meaningful tracking over time, helping distinguish normal age-related changes from early cognitive decline. Regular assessment allows for earlier intervention if changes are detected, and provides objective data to guide lifestyle modifications aimed at maintaining cognitive health.
Disclaimer
Preventive cancer panel
Multi-cancer early detection surveillance
$499
Includes 1:1 doctor consultation
Who this panel is for
For individuals who want proactive health surveillance—especially those with a family history of cancer or heightened concern about long-term risk.
What this panel helps you understand
Whether early biological signals warrant closer attention
If your internal environment leans toward inflammation or protection
Whether monitoring should increase or lifestyle optimisation is sufficient
What it looks at
A contextual view of cancer-related risk, including:
Biomarkers associated with key cancer pathways
Inflammatory and immune signals linked to risk modulation
Indicators of organ-specific stress
Why this matters
Cancer risk can develop gradually. This panel helps establish a clear baseline of traditional tumour markers (CEA, CA 19-9, AFP, PSA/CA 125) so you and your doctor can track changes over time, rather than relying on a single snapshot.
Whether you're monitoring your health proactively or after treatment, stable results offer peace of mind, while meaningful shifts signal when to pay closer attention—empowering you to make informed decisions with confidence.
How this supports better decisions
Helps distinguish when reassurance is appropriate versus when closer investigation may be warranted
Guides nutrition and inflammation-reducing strategies
Enables timely intervention while reducing unnecessary anxiety about unknown risk
Panel includes:
CEA
Carcinoembryonic antigen is a protein that may rise in colorectal and other cancers. While not diagnostic on its own due to elevations from smoking or inflammation, a baseline CEA allows meaningful trend tracking over time. Rising levels warrant evaluation and are particularly useful for detecting recurrence or monitoring treatment response in individuals with known cancer history.
Disclaimer
AFP
Alpha-fetoprotein is a protein used primarily for liver cancer surveillance, especially in individuals with hepatitis, cirrhosis, or chronic liver disease. Rising AFP levels may signal changes in liver health that warrant closer monitoring or follow-up. Baseline measurement enables longitudinal monitoring, with elevated levels warranting further assessment.
Disclaimer
CA 19-9
CA 19-9 is most closely associated with pancreatic and biliary cancers. Although unsuitable for routine screening, it provides valuable baseline data and aids early investigation when levels rise over time, particularly in those with symptoms or family history. It is also useful for monitoring treatment response in individuals with diagnosed disease.
Disclaimer
PSA (total and free) – males only
Prostate-specific antigen is the standard blood marker for prostate cancer screening. Total PSA may rise in benign or malignant conditions, while the free-to-total PSA ratio improves risk assessment, with lower ratios suggesting higher cancer risk. Monitoring PSA trends is especially informative, as rapid increases may signal concern even at modest absolute levels. Your physician will interpret your results in the context of your age, symptoms, and risk factors.
Disclaimer
CA 125 – females only
CA 125 is associated with ovarian cancer but can also rise in benign gynecological conditions. It is most useful when combined with symptoms and pelvic imaging, as ovarian cancer is difficult to detect early. Establishing a baseline supports trend monitoring, with rising values prompting further evaluation.
Disclaimer
SPOT-MAS test (optional) $890
Coming soon. For more comprehensive screening, add SPOT-MAS to your panel. This multi-cancer early detection test uses advanced circulating tumour DNA (ctDNA) analysis to screen for 10 common cancer types, often before any symptoms appear. It provides an additional layer of vigilance, helping you catch potential risks sooner. Ideal for those seeking proactive, broader surveillance beyond traditional markers.
Disclaimer
LucenceINSIGHT 50 test (optional) $3999
Coming soon. For the most extensive insight into your health, upgrade to Lucence MCED (Multi-Cancer Early Detection). As our most advanced screening solution, this single blood test expands your coverage to over 50 different types of cancer. By providing the widest possible net for early detection, Lucence MCED offers the ultimate peace of mind for you and your family. Recommended for individuals with a family history of cancer or those who want the most thorough screening available.
Disclaimer
Disclaimer:
Tumour markers and MCED tests are not diagnostic for cancer and are not recommended for general population screening. Elevated levels may be caused by non-cancerous conditions such as inflammation, infection, or benign growths. Similarly, normal results do not exclude the presence of cancer. This panel establishes baseline values for longitudinal monitoring and should not replace age-appropriate cancer screening (such as colonoscopy, mammography, or other recommended tests). These results must be interpreted alongside clinical findings and other investigations by your physician.
Preventive cancer panel
Multi-cancer early detection surveillance
$499
Includes 1:1 doctor consultation
Who this panel is for
For individuals who want proactive health surveillance—especially those with a family history of cancer or heightened concern about long-term risk.
What this panel helps you understand
Whether early biological signals warrant closer attention
If your internal environment leans toward inflammation or protection
Whether monitoring should increase or lifestyle optimisation is sufficient
What it looks at
A contextual view of cancer-related risk, including:
Biomarkers associated with key cancer pathways
Inflammatory and immune signals linked to risk modulation
Indicators of organ-specific stress
Why this matters
Cancer risk can develop gradually. This panel helps establish a clear baseline of traditional tumour markers (CEA, CA 19-9, AFP, PSA/CA 125) so you and your doctor can track changes over time, rather than relying on a single snapshot.
Whether you're monitoring your health proactively or after treatment, stable results offer peace of mind, while meaningful shifts signal when to pay closer attention—empowering you to make informed decisions with confidence.
How this supports better decisions
Helps distinguish when reassurance is appropriate versus when closer investigation may be warranted
Guides nutrition and inflammation-reducing strategies
Enables timely intervention while reducing unnecessary anxiety about unknown risk
Panel includes:
CEA
Carcinoembryonic antigen is a protein that may rise in colorectal and other cancers. While not diagnostic on its own due to elevations from smoking or inflammation, a baseline CEA allows meaningful trend tracking over time. Rising levels warrant evaluation and are particularly useful for detecting recurrence or monitoring treatment response in individuals with known cancer history.
Disclaimer
AFP
Alpha-fetoprotein is a protein used primarily for liver cancer surveillance, especially in individuals with hepatitis, cirrhosis, or chronic liver disease. Rising AFP levels may signal changes in liver health that warrant closer monitoring or follow-up. Baseline measurement enables longitudinal monitoring, with elevated levels warranting further assessment.
Disclaimer
CA 19-9
CA 19-9 is most closely associated with pancreatic and biliary cancers. Although unsuitable for routine screening, it provides valuable baseline data and aids early investigation when levels rise over time, particularly in those with symptoms or family history. It is also useful for monitoring treatment response in individuals with diagnosed disease.
Disclaimer
PSA (total and free) – males only
Prostate-specific antigen is the standard blood marker for prostate cancer screening. Total PSA may rise in benign or malignant conditions, while the free-to-total PSA ratio improves risk assessment, with lower ratios suggesting higher cancer risk. Monitoring PSA trends is especially informative, as rapid increases may signal concern even at modest absolute levels. Your physician will interpret your results in the context of your age, symptoms, and risk factors.
Disclaimer
CA 125 – females only
CA 125 is associated with ovarian cancer but can also rise in benign gynecological conditions. It is most useful when combined with symptoms and pelvic imaging, as ovarian cancer is difficult to detect early. Establishing a baseline supports trend monitoring, with rising values prompting further evaluation.
Disclaimer
SPOT-MAS test (optional) $890
Coming soon. For more comprehensive screening, add SPOT-MAS to your panel. This multi-cancer early detection test uses advanced circulating tumour DNA (ctDNA) analysis to screen for 10 common cancer types, often before any symptoms appear. It provides an additional layer of vigilance, helping you catch potential risks sooner. Ideal for those seeking proactive, broader surveillance beyond traditional markers.
Disclaimer
LucenceINSIGHT 50 test (optional) $3999
Coming soon. For the most extensive insight into your health, upgrade to Lucence MCED (Multi-Cancer Early Detection). As our most advanced screening solution, this single blood test expands your coverage to over 50 different types of cancer. By providing the widest possible net for early detection, Lucence MCED offers the ultimate peace of mind for you and your family. Recommended for individuals with a family history of cancer or those who want the most thorough screening available.
Disclaimer
Disclaimer:
Tumour markers and MCED tests are not diagnostic for cancer and are not recommended for general population screening. Elevated levels may be caused by non-cancerous conditions such as inflammation, infection, or benign growths. Similarly, normal results do not exclude the presence of cancer. This panel establishes baseline values for longitudinal monitoring and should not replace age-appropriate cancer screening (such as colonoscopy, mammography, or other recommended tests). These results must be interpreted alongside clinical findings and other investigations by your physician.
1Notes on interpretation
Important: Individual biomarker results should always be interpreted in the context of your complete health profile, family history, symptoms, and other test results. These markers are screening tools that may prompt further investigation—they are not diagnostics on their own.
For optimal use: Your physician will review these results during your consultation and create a personalised health optimisation or disease prevention plan based on your unique risk profile and health goals.
$1299
Preventive panel bundle
1
(Includes 1:1 doctor consultation)
A comprehensive screening panel for health-conscious individuals who want to identify hidden cardiovascular, metabolic, and cancer risks before symptoms appear. This bundle combines advanced lipid analysis, multi-cancer early detection, and foundational metabolic screening to reveal risks that standard panels miss.
Coming soon.
Who this panel is for
For individuals who want real clarity on cardiovascular risk—especially if you have a family history, are a high performer, or want deeper clarity beyond basic cholesterol testing.
What this panel helps you understand
Whether your risk is truly low or simply “normal” on standard tests
If plaque formation or vascular stress is developing quietly
Whether your lipid profile is protective or harmful over the long-term
What it looks at
A deeper view of heart health, including:
Cholesterol particle quality, not just total cholesterol numbers
Inflammatory signals affecting blood vessels
Early markers of cardiovascular strain before symptoms appear
Why this matters
Heart disease is often silent until late stages
Standard tests can miss risk in fit, lean, or active individuals
Earlier insight creates more room for prevention and course correction
How this supports better decisions
Enables more personalised nutrition beyond generic “heart-healthy” advice
Guides the right type and intensity of exercise
Clarifies when lifestyle optimisation is enough and when closer monitoring is needed
Panel includes:
NT-proBNP
N-terminal pro-B-type natriuretic peptide is a hormone released when the heart muscle is under strain. Elevated levels signal early cardiac stress from conditions such as high blood pressure, valve disease, or developing heart failure—often long before symptoms like breathlessness or fatigue appear. NT-proBNP offers early clarity on how the heart is responding to strain, helping guide timely lifestyle or care adjustments and track changes over time.
Disclaimer
Homocysteine
Homocysteine is an amino acid produced during protein metabolism that can damage blood vessel walls when elevated. High levels are independently linked to heart attack, stroke, peripheral artery disease, and dementia, driven by vascular inflammation and plaque formation. Homocysteine also reflects functional status of key B vitamins—B12, folate, and B6—and is highly actionable, as levels often improve with targeted nutritional intervention, making it valuable for cardiovascular and brain risk optimisation.
Disclaimer
ApoA1
Apolipoprotein A1 is the main structural protein of HDL particles responsible for removing cholesterol from artery walls and transporting it back to the liver. Measuring ApoA1 reflects the number and effectiveness of protective HDL particles rather than cholesterol content alone, which can be misleading. Higher levels are associated with stronger cardiovascular protection, while lower levels indicate impaired cholesterol clearance even when HDL cholesterol appears normal.
Disclaimer
ApoB/ApoA1 ratio
Apolipoprotein B/Apolipoprotein A1 ratio represents the balance between atherogenic particles and protective HDL particles in a single, powerful metric. It captures net cardiovascular risk more accurately than traditional cholesterol ratios, showing whether harmful particles outweigh the body's ability to clear them. Lower ratios indicate favourable lipid balance and reduced cardiovascular risk, while higher ratios signal the need for intervention.
Disclaimer
Lp(a)
Lipoprotein(a), or lipoprotein little a, is a genetically determined LDL-like particle with an added protein that promotes inflammation and clot formation. Levels are largely fixed for life and minimally influenced by lifestyle, yet significantly increase risk of heart attack, stroke, and aortic valve disease. Testing Lp(a) enables lifetime risk stratification and identifies individuals who benefit from more aggressive management of all modifiable cardiovascular risk factors. Elevated levels warrant enhanced prevention efforts.
Disclaimer
Who this panel is for
For individuals who want real clarity on cardiovascular risk—especially if you have a family history, are a high performer, or want deeper clarity beyond basic cholesterol testing.
What this panel helps you understand
Whether your risk is truly low or simply “normal” on standard tests
If plaque formation or vascular stress is developing quietly
Whether your lipid profile is protective or harmful over the long-term
What it looks at
A deeper view of heart health, including:
Cholesterol particle quality, not just total cholesterol numbers
Inflammatory signals affecting blood vessels
Early markers of cardiovascular strain before symptoms appear
Why this matters
Heart disease is often silent until late stages
Standard tests can miss risk in fit, lean, or active individuals
Earlier insight creates more room for prevention and course correction
How this supports better decisions
Enables more personalised nutrition beyond generic “heart-healthy” advice
Guides the right type and intensity of exercise
Clarifies when lifestyle optimisation is enough and when closer monitoring is needed
Panel includes:
NT-proBNP
N-terminal pro-B-type natriuretic peptide is a hormone released when the heart muscle is under strain. Elevated levels signal early cardiac stress from conditions such as high blood pressure, valve disease, or developing heart failure—often long before symptoms like breathlessness or fatigue appear. NT-proBNP offers early clarity on how the heart is responding to strain, helping guide timely lifestyle or care adjustments and track changes over time.
Disclaimer
Homocysteine
Homocysteine is an amino acid produced during protein metabolism that can damage blood vessel walls when elevated. High levels are independently linked to heart attack, stroke, peripheral artery disease, and dementia, driven by vascular inflammation and plaque formation. Homocysteine also reflects functional status of key B vitamins—B12, folate, and B6—and is highly actionable, as levels often improve with targeted nutritional intervention, making it valuable for cardiovascular and brain risk optimisation.
Disclaimer
ApoA1
Apolipoprotein A1 is the main structural protein of HDL particles responsible for removing cholesterol from artery walls and transporting it back to the liver. Measuring ApoA1 reflects the number and effectiveness of protective HDL particles rather than cholesterol content alone, which can be misleading. Higher levels are associated with stronger cardiovascular protection, while lower levels indicate impaired cholesterol clearance even when HDL cholesterol appears normal.
Disclaimer
ApoB/ApoA1 ratio
Apolipoprotein B/Apolipoprotein A1 ratio represents the balance between atherogenic particles and protective HDL particles in a single, powerful metric. It captures net cardiovascular risk more accurately than traditional cholesterol ratios, showing whether harmful particles outweigh the body's ability to clear them. Lower ratios indicate favourable lipid balance and reduced cardiovascular risk, while higher ratios signal the need for intervention.
Disclaimer
Lp(a)
Lipoprotein(a), or lipoprotein little a, is a genetically determined LDL-like particle with an added protein that promotes inflammation and clot formation. Levels are largely fixed for life and minimally influenced by lifestyle, yet significantly increase risk of heart attack, stroke, and aortic valve disease. Testing Lp(a) enables lifetime risk stratification and identifies individuals who benefit from more aggressive management of all modifiable cardiovascular risk factors. Elevated levels warrant enhanced prevention efforts.
Disclaimer
Featured doctors
Featured doctors
Featured doctors
Clinically led. Scientifically structured.
Clinically led. Scientifically structured.
Clinically led. Scientifically structured.
These doctors lead your 1:1 consultations and group discussions tailored to your chosen service, serving as your partners in optimising healthspan through lifestyle medicine.
Dr. Eva-Leina Yoosuff
A medical doctor and certified health coach with 15+ years of experience, blending clinical expertise and behavioural coaching.
Dr. Eva-Leina Yoosuff
A medical doctor and certified health coach with 15+ years of experience, blending clinical expertise and behavioural coaching.
Dr. Eva-Leina Yoosuff
A medical doctor and certified health coach with 15+ years of experience, blending clinical expertise and behavioural coaching.
Dr. Ari Ali Sahebkashaf
A medical doctor with over a decade of clinical and preventive health experience, guiding individuals with evidence-based, lifestyle-focused care.
Dr. Ari Ali Sahebkashaf
A medical doctor with over a decade of clinical and preventive health experience, guiding individuals with evidence-based, lifestyle-focused care.
Dr. Ari Ali Sahebkashaf
A medical doctor with over a decade of clinical and preventive health experience, guiding individuals with evidence-based, lifestyle-focused care.
Simon Matthews
Head of Health Coaching and Psychology
Simon Matthews
Head of Health Coaching and Psychology
Claudia Correia
Head of Dietetics and Nutrition
Claudia Correia
Head of Dietetics and Nutrition
Stuart Bauld
Head of Exercise Science
Stuart Bauld
Head of Exercise Science
Supported by allied health professionals.
When specialised care is needed, we refer patients to our multi-disciplinary team and integrate their input into your broader lifestyle plan. MORROW Medical is the central guide — helping you make sustainable lifestyle changes while ensuring their care is consistent, holistic, and aligned across all providers.
Health coaches
Physiotherapists
Dietitians
Clinical psychologists
Counsellors
Simon Matthews
Head of Health Coaching and Psychology
Simon Matthews
Head of Health Coaching and Psychology
Claudia Correia
Head of Dietetics and Nutrition
Claudia Correia
Head of Dietetics and Nutrition
Stuart Bauld
Head of Exercise Science
Stuart Bauld
Head of Exercise Science
Change begins with clarity
Check Your Health
Check Your Health
Change begins with clarity
Check Your Health
All healthcare services are provided by Longevity & Lifestyle Medical Pte. Ltd., which operates under the brand “MORROW Medical”, and is licensed by the Ministry of Health under the Healthcare Services Act 2020 (Licence Number: L/25M0780/MDS/001/252). MORROW Medical is part of the MORROW group that includes MORROW Health Pte. Ltd., which operates under the brand “MORROW”.
© 2026 Longevity & Lifestyle Medical Pte Ltd
Subscribe to our newsletter
Get the latest news and stay connected with MORROW.
Subscribe to our newsletter
Get the latest news and stay connected with MORROW.
All healthcare services are provided by Longevity & Lifestyle Medical Pte. Ltd., which operates under the brand “MORROW Medical”, and is licensed by the Ministry of Health under the Healthcare Services Act 2020 (Licence Number: L/25M0780/MDS/001/252). MORROW Medical is part of the MORROW group that includes MORROW Health Pte. Ltd., which operates under the brand “MORROW”.
© 2026 Longevity & Lifestyle Medical Pte Ltd
All healthcare services are provided by Longevity & Lifestyle Medical Pte. Ltd., which operates under the brand “MORROW Medical”, and is licensed by the Ministry of Health under the Healthcare Services Act 2020 (Licence Number: L/25M0780/MDS/001/252). MORROW Medical is part of the MORROW group that includes MORROW Health Pte. Ltd., which operates under the brand “MORROW”.
© 2026 Longevity & Lifestyle Medical Pte Ltd
Subscribe to our newsletter
Get the latest news and stay connected with MORROW.